Jiangsu Aidea Pharmaceutical Co Ltd (688488) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Jiangsu Aidea Pharmaceutical Co Ltd (688488) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥3.56 Million ≈ $521.57K USD) by net assets (CN¥1.08 Billion ≈ $158.33 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 688488 company net worth for the company's overall valuation and market capitalisation.

Jiangsu Aidea Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Jiangsu Aidea Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Jiangsu Aidea Pharmaceutical Co Ltd stock quote for real-time trading data and today's change.

Jiangsu Aidea Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangsu Aidea Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Review 688488 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Company	Cash Flow Conversion Efficiency
Shantou Wanshun Package Material SHE:300057	-0.015x
Beijing Shenzhou Aerospace Software Technology Co. Ltd. A SHG:688562	N/A
D-MARKET E.S.+T.SP.ADR/1B F:8WZ	-3.858x
Forum Energy Technologies Inc NYSE:FET	0.043x
Hunan Heshun Petroleum Co Ltd SHG:603353	0.114x
Shantou Dongfeng Printing Co Ltd SHG:601515	-0.004x
Everforth, Inc. NYSE:EFOR	0.010x
Zhenjiang Dongfang Electric Heat SHE:300217	0.034x

Annual Cash Flow Conversion Efficiency for Jiangsu Aidea Pharmaceutical Co Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Jiangsu Aidea Pharmaceutical Co Ltd from 2016 to 2025. Also see Jiangsu Aidea Pharmaceutical Co Ltd total assets for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.07 Billion ≈ $157.05 Million	CN¥17.63 Million ≈ $2.58 Million	0.016x	+146.75%
2024-12-31	CN¥1.07 Billion ≈ $156.15 Million	CN¥-37.50 Million ≈ $-5.49 Million	-0.035x	+76.21%
2023-12-31	CN¥1.13 Billion ≈ $164.70 Million	CN¥-166.22 Million ≈ $-24.32 Million	-0.148x	-91.31%
2022-12-31	CN¥1.20 Billion ≈ $175.45 Million	CN¥-92.55 Million ≈ $-13.54 Million	-0.077x	-717.31%
2021-12-31	CN¥1.31 Billion ≈ $191.66 Million	CN¥-12.37 Million ≈ $-1.81 Million	-0.009x	-122.87%
2020-12-31	CN¥1.36 Billion ≈ $198.99 Million	CN¥56.17 Million ≈ $8.22 Million	0.041x	-59.12%
2019-12-31	CN¥556.24 Million ≈ $81.39 Million	CN¥56.20 Million ≈ $8.22 Million	0.101x	+257.64%
2018-12-31	CN¥522.71 Million ≈ $76.49 Million	CN¥-33.50 Million ≈ $-4.90 Million	-0.064x	+50.96%
2017-12-31	CN¥514.09 Million ≈ $75.23 Million	CN¥-67.18 Million ≈ $-9.83 Million	-0.131x	-225.46%
2016-12-31	CN¥300.40 Million ≈ $43.96 Million	CN¥31.29 Million ≈ $4.58 Million	0.104x	--

About Jiangsu Aidea Pharmaceutical Co Ltd

SHG:688488 China Biotechnology

Market Cap

$833.71 Million

CN¥5.70 Billion CNY

Market Cap Rank

#9538 Global

#2374 in China

Share Price

CN¥13.54

Change (1 day)

-2.94%

52-Week Range

CN¥11.59 - CN¥22.16

All Time High

CN¥42.39